The relationship between the concentration of dextran sodium sulfate and the degree of induced experimental colitis in weanling rats

被引:41
作者
Shimizu, T [1 ]
Suzuki, M [1 ]
Fujimura, J [1 ]
Hisada, K [1 ]
Yoshikazu, O [1 ]
Obinata, K [1 ]
Yamashiro, Y [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Pediat, Bunkyo Ku, Tokyo 1130033, Japan
关键词
dextran sodium sulfate; ulcerative colitis; leukotriene B mucosal blood flow; rat;
D O I
10.1097/00005176-200310000-00015
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Although a dextran sodium sulfate (DSS)-induced colitis is commonly used as an ulcerative colitis (UC) model in adult rodents, there are no studies using this model in young animals. We examined differences in the severity of DSS-induced colitis as a function of the concentration of DSS administered and sought to establish a DSS-induced colitis model in young rats. Methods: We administrated different concentrations of DSS solution (2%, 3%, and 4%) to 4-week-old weanling rats and compared their clinical findings, colonic histologic findings, mucosal leukotriene B-4 (LTB4) production, and mucosal blood flow with control weanling rats and 8-week-old adult rats given 4% DSS for induced colitis. Results: Clinical symptoms, such as diarrhea and rectal bleeding, histologic findings, and disturbance of mucosal microcirculation in weanling rats given 4% DSS were significantly more severe than those in adult rats given the same treatment. Three of 10 rats given 2% DSS had no bloody stool and 2 of 10 rats given 4% DSS died during the experimental periods. Clinical symptoms, hemoglobin levels, histologic damage scores, mucosal LTB4 production, and mucosal blood flow became more severely deranged as the concentration of DSS increased from 2% to 4%. Conclusion: These findings suggest that we can adjust disease severity in UC model for young children by giving different concentrations of DSS to weanling rats. (C) 2003 Lippincott Williams Wilkins, Inc.
引用
收藏
页码:481 / 486
页数:6
相关论文
共 23 条
[1]
Butyrate and glucose metabolism by colonocytes in experimental colitis in mice [J].
Ahmad, MS ;
Krishnan, S ;
Ramakrishna, BS ;
Mathan, M ;
Pulimood, AB ;
Murthy, SN .
GUT, 2000, 46 (04) :493-499
[2]
Araki Y, 2000, CLIN EXP IMMUNOL, V119, P264
[3]
BOJRCK S, 1997, DIGEST DIS SCI, V41, P824
[4]
Characterisation of acute murine dextran sodium sulphate colitis:: Cytokine profile and dose dependency [J].
Egger, B ;
Bajaj-Elliott, M ;
MacDonald, TT ;
Inglin, R ;
Eysselein, VE ;
Büchler, MW .
DIGESTION, 2000, 62 (04) :240-248
[6]
THE EFFECT OF LEUKOTRIENE-B4 RECEPTOR ANTAGONIST, SC-41930, ON ACETIC ACID-INDUCED COLONIC INFLAMMATION [J].
FRETLAND, DJ ;
LEVIN, S ;
TSAI, BS ;
DJURIC, SW ;
WIDOMSKI, DL ;
ZEMAITIS, JM ;
SHONE, RL ;
BAUER, RF .
AGENTS AND ACTIONS, 1989, 27 (3-4) :395-397
[7]
Dextran sulfate sodium (DSS) colitis in rats - Clinical, structural, and ultrastructural aspects [J].
Gaudio, E ;
Taddei, G ;
Vetuschi, A ;
Sferra, R ;
Frieri, G ;
Ricciardi, G ;
Caprilli, R .
DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (07) :1458-1475
[8]
GUSLANDI M, 1995, AM J GASTROENTEROL, V90, P579
[9]
KOBAYASHI K, 1988, J CLIN LAB IMMUNOL, V25, P63
[10]
Inflammatory bowel diseases with onset in childhood - Clinical features, morbidity, and mortality in a regional cohort [J].
Langholz, E ;
Munkholm, P ;
Krasilnikoff, PA ;
Binder, V .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (02) :139-147